Guoying Wang
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 21
- Hepatocellular Carcinoma Treatment and Prognosis 16
-
- Cancer, Lipids, and Metabolism 11
- MicroRNA in disease regulation 9
- Co-authors
- Alana L. WelmBryan E. WelmYoko S. DeRoseQi ZhangGuihua ChenShizhen ZhongGenshu WangYinan Deng
- Journals
- Liver Research (5 papers)Developmental Biology (5 papers)Annals of Translational Medicine (3 papers)World Journal of Gastroenterology (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Guoying Wang
132 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Hepatology 642
- Cancer Research 1.0k
- Oncology 1.1k
- Molecular Biology 1.6k
- Biotechnology 182
Countries citing papers authored by Guoying Wang
This map shows the geographic impact of Guoying Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoying Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoying Wang more than expected).
Fields of papers citing papers by Guoying Wang
This network shows the impact of papers produced by Guoying Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoying Wang. The network helps show where Guoying Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guoying Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Hit paper breakdown → | 2022 | 262 |
| 7 | 2021 | 3 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 117 | |
| 10 | Three Isoforms of Exosomal circPTGR1 Promote Hepatocellular Carcinoma Metastasis Via the miR449a/MET Pathway | 2018 | 6 |
| 11 | 2018 | 1 | |
| 12 | 2017 | 49 | |
| 13 | 2014 | 87 | |
| 14 | 2013 | 12 | |
| 15 | [The epidemiology of dentine hypersensitivity among adults in Shanghai municipality]. | 2009 | 8 |
| 16 | 2007 | 22 | |
| 17 | 2006 | 76 | |
| 18 | A Method of Image Retrieval Based on Color Coherence Vector | 2006 | 3 |
| 19 | [The relationship between N-myc downstream regulated gene 1 and neoplasms]. | 2003 | 3 |
| 20 | 2001 | 15 |
About Guoying Wang
Guoying Wang is a scholar working on Hepatology, Cancer Research, Oncology, Developmental Neuroscience and Transplantation, having authored 141 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (15 papers), Cancer, Lipids, and Metabolism (11 papers), Organ Transplantation Techniques and Outcomes (10 papers), MicroRNA in disease regulation (9 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers), RNA modifications and cancer (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Hepatology (642 citations), Cancer Research (1.0k citations), Oncology (1.1k citations), Molecular Biology (1.6k citations) and Biotechnology (182 citations). Guoying Wang has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Alana L. Welm, Bryan E. Welm, Yoko S. DeRose, Qi Zhang, Guihua Chen, Shizhen Zhong, Genshu Wang, Yinan Deng, Cindy Matsen and Saundra S. Buys. Their work appears in journals such as Liver Research, Developmental Biology, Annals of Translational Medicine, World Journal of Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.